Clinical trials
Withdrawn Autism Spectrum Disorder trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
35 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 1 |
| 2014 | 3 |
| 2015 | 2 |
| 2016 | 1 |
| 2018 | 2 |
| 2019 | 2 |
| 2020 | 5 |
| 2021 | 5 |
| 2022 | 6 |
| 2023 | 1 |
| 2024 | 2 |
| 2025 | 1 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 35 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Stanford University | 3 |
| Massachusetts General Hospital | 2 |
| National Institute of Mental Health (NIMH) | 2 |
| Beth Israel Deaconess Medical Center | 1 |
| Boston Medical Center | 1 |
| Boston University Charles River Campus | 1 |
| China Medical University Hospital | 1 |
| Cognoa, Inc. | 1 |
| Duke University | 1 |
| Edison Pharmaceuticals Inc | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Autism Spectrum Disorder | 35 |
| Autistic Disorder | 13 |
| Child Development Disorders, Pervasive | 6 |
| Anxiety Disorders | 3 |
| Akinetic Mutism | 1 |
| Angelman Syndrome | 1 |
| Antisocial Personality Disorder | 1 |
| Asperger Syndrome | 1 |
| Attention Deficit Disorder with Hyperactivity | 1 |
| Developmental Disabilities | 1 |
Trials
Showing 76 to 35 of 35. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.